Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

Heavy Dilution From Cashless Warrants Is Forcing Naked Stock Down

By Mark R. Hake, CFA
Heavy dilution from cashless warrants is forcing NAKD stock down. NAKD stock will likely fall to 48 cents per share as hedge funds arbitrage the dilution.

Bionano Genomics Stock Has Huge Potential, But It’s Very Risky

By Vince Martin, InvestorPlace Contributor
BNGO stock is a play on a potentially disruptive technology. But investors can't forget that most potentially disruptive technologies fail.

You Don’t Want to Be the Last to Know What Zomedica Stock Is Really Worth

By Vince Martin, InvestorPlace Contributor
The retirement of preferred stock seems like a clear win for Zomedica and ZOM stock. But the deal raises a key question as well.

It’s Time to Sell Overvalued QuantumScape Stock

By Larry Ramer, InvestorPlace Contributor
QuantumScape has had a number of positive developments, but the company still faces huge hurdles and QS stock is overvalued.

Ideanomics Is Not Worth the Sum of Its Parts

By Mark R. Hake, CFA
Ideanomics now has a combination of EV-related and non-EV-related segments. Unfortunately, IDEX stock is not worth the sum of these parts.

Be a Smart Horse, Not a Workhorse

By Josh Enomoto, InvestorPlace Contributor
Although WKHS stock wins the popularity argument, the reality is that its core competitor has the overall superior solution.

Catalysts Aside, Tilray Stock Remains a Cannabis Name to Avoid

By InvestorPlace Research Staff
Even with the global legalization trend, and its upcoming merger, you should consider other cannabis plays over TLRY stock.

Is AMC a $5 or a $15 Stock at This Point in the Proceedings?

By Will Ashworth, InvestorPlace Contributor
AMC stock has spent most of 2021 gyrating between $5 and $15. It's at a fork in the road. I’d pass at anything over $7.50.

GameStop Serves Food for the Bears

By Stavros Georgiadis, CFA, InvestorPlace Contributor
GME stock is trying to become more than a meme stock, but wishful thinking does not justifying its lofty valuation.

5 Extremely Overvalued Stocks to Sell Right Now

By Stavros Georgiadis, CFA, InvestorPlace Contributor
Overvalued stocks at record highs for major stock indices are too risky. These 5 stocks are too overvalued to own now.

3 Gun Stocks to Sell Should Gun Control Gain Steam

By Thomas Niel, InvestorPlace Contributor
With more stringent gun laws possibly on the horizon, it may be time to cash out of these three gun company stocks.

Genius Brands Stock Has Future Potential, but Stay Clear at These Prices

By Larry Ramer, InvestorPlace Contributor
Genius Brands is doing many things right, but the valuation of GNUS stock is really out-of-this world right now.

7 F-Rated Tech Stocks to Avoid Today

By Louis Navellier and the InvestorPlace Research Staff
Tech stocks can deliver spectacular growth, but when companies face big challenges and shares start sliding, it may be best to avoid them.

Pent-Up Post-Lockdown Demand, EV Fatigue May Keep Churchill Capital IV in Check

By Chris Markoch, InvestorPlace Contributor
Due to the intensified competition for discretionary dollars, CCIV stock could be kept in check for some time.

Why the Meme Stock Crowd Is Wrong About Castor Maritime Stock

By Chris MacDonald, InvestorPlace Contributor
Meme stock investors have helped cause a parabolic move in CTRM stock, but here's why that sort of swing is unlikely to materialize again.

Steer Clear of Overvalued Airbnb Stock

By InvestorPlace Research Staff
ABNB stock has seen a monster rally since last year's IPO. But a focus on near-term normalcy ignores significant long-term problems.

If You Rode the Co-Diagnostics Stock Pandemic Highs, It’s Time to Bail

By Alex Sirois, InvestorPlace Contributor
CODX stock rose on the pandemic, but its prospects moving forward look bleak with a sales strategy that is suspect at best.

Kandi Technologies Can Hardly Be Considered an EV Play

By Alex Sirois, InvestorPlace Contributor
KNDI stock represents a company that wanted to take advantage of the EV wave but simply didn't have a viable business model.

Aurinia Stock Has Great Potential, but It’s Not a Buy Right Now

By Alex Sirois, InvestorPlace Contributor
AUPH stock still has to prove its Lupus drug can sell and its price and the competition make that an unclear proposition.
Load More Articles